Quantcast

Latest Dabigatran Stories

2014-04-07 08:31:34

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 7, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-05 23:03:33

A new lawsuit was filed on March 27, by a man in Texas Southern District Court alleging that he suffered a severe gastrointestinal bleed from Pradaxa. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) April 04, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and now,...

2014-04-04 23:30:56

The Firm is evaluating Pradaxa lawsuits on behalf of patients who suffered uncontrollable internal bleeding, allegedly due to Pradaxa. New York, NY (PRWEB) April 03, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) that allege the medication caused patients to suffer uncontrollable internal bleeding continue to move forward, Bernstein Liebhard LLP notes that a new study indicates there could soon be an antidote for Pradaxa’s bleeding side effects. The research, which was...

2014-04-02 23:33:40

Boehringer Ingelheim ordered to pay nearly $1 million fine for obstructing pre-trial evidence gathering. National network of attorneys continues policy of no-cost consultations to consumers inquiring about legal options to seek compensation over these allegations. San Diego, CA (PRWEB) April 02, 2014 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople today announced important new developments involving lawsuits* alleging that the popular...

2014-03-29 23:02:26

The Firm is evaluating Pradaxa lawsuits on behalf of patients who suffered episodes of uncontrollable hemorrhaging, allegedly due to their use of Pradaxa. New York, New York (PRWEB) March 29, 2014 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of patients who allegedly suffered serious episodes of uncontrollable hemorrhaging due to their use of the blood thinner continue to mount in federal court, Bernstein Liebhard LLP reports. According court documents, at least...

2014-03-28 23:25:44

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) March 28, 2014 The prescription drug safety center DrugRisk.com is announcing updated legal news on the site for patients taking the blood thinner Pradaxa. Recent court documents show a federal court has scheduled the first lawsuit alleging the drug caused internal bleeding injury or death to start in...

2014-03-28 08:27:23

Cardiologists also believe their patients' top concern is the fear of experiencing a clot that leads to a stroke; real-world challenges may influence treatment decisions RIDGEFIELD, Conn., March 28, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced results from a new survey of cardiologists to understand their perceptions about anticoagulation, stroke risk reduction and goals for non-valvular atrial fibrillation (NVAF) therapy when prescribing warfarin or...

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...

2014-03-24 08:26:49

Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies WALTHAM, Mass., March 24, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of the largest-ever study of warfarin patient self-testing, which demonstrated that weekly International Normalized Ratio (INR) testing significantly improves control of warfarin, as measured...

2014-03-23 23:02:28

The Firm is evaluating Pradaxa lawsuits on behalf of patients who suffered episodes of uncontrollable internal bleeding, allegedly due to their use of Pradaxa. New York, New York (PRWEB) March 23, 2014 A status conference will be held on April 9, 2014, to address the thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) currently pending in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related